French biotech firm Standing Ovation has raised EUR 3 million (~USD 3.3 million) in funding, consisting of a EUR 2 million (~USD 2.2 million) grant from the French government and EUR 1 million (~USD 1.1 million) in debt financing from Bpifrance.
The new funds will be used to develop a purification line as part of the CASPEX project, which aims to produce caseins on a large scale. The purification process will aid in the extraction of caseins, improving efficiency and reducing production costs.
Analyst QuickTake: This new capital influx follows Standing Ovation’s EUR 12 million (~USD 12 million) oversubscribed Series A funding round. While undisclosed at the time, Bel Group, a major dairy product producer, was among the investors of this round. Bel Group also entered an R&D partnership with the company, with the debut products from this collaboration slated for early 2024.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.